Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cyclo Therapeutics Inc
(NQ:
CYTH
)
1.235
UNCHANGED
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cyclo Therapeutics Inc
< Previous
1
2
3
Next >
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
November 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Atea Announces Termination of Strategic Collaboration With Roche Atea...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 17, 2021
Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
November 17, 2021
Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Fed Speakers
November 17, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after closing mostly flat in the prior session. Investors are awaiting earnings results from Lowe`s...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
5 Stocks To Watch For November 17, 2021
November 17, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Lowe`s Companies Inc (NYSE: LOW) to report quarterly earnings at $2.35 per share on revenue of $...
Via
Benzinga
Cyclo Therapeutics Shares Jump After Filing To Start Alzheimer's Trial In US
November 16, 2021
Cyclo Therapeutics Inc (NASDAQ: CYTH) has submitted its initial investigational new drug (IND) application with the FDA for a Phase 2 study of Trappsol Cyclo for...
Via
Benzinga
Exposures
Product Safety
Cyclo Therapeutics' Trappsol Shows Early Safety, Efficacy In Genetic Disorder
July 30, 2021
Cyclo Therapeutics Inc (NASDAQ: CYTH) has announced new data from its Phase 1 extension study evaluating Trappsol Cyclo Niemann-Pick Disease Type C1 (NPC), a...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 22, 2021
Gainers vTv Therapeutics (NASDAQ:VTVT) shares rose 30.08% to $3.07 during Tuesday's pre-market session. The company's market cap stands at $251.7 million. Adial...
Via
Benzinga
Cyclo Therapeutics Shares Move Higher On Kickstart Of Late-Stage NPC Trial With Trappsol Cyclo
June 17, 2021
Cyclo Therapeutics Inc (NASDAQ: CYTH) has commenced its pivotal Phase 3 study (TransportNPC) evaluating Trappsol Cyclo for Niemann-Pick Disease Type C1 (NPC1). The...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
June 14, 2021
Gainers RAPT Therapeutics (NASDAQ:RAPT) s...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 24, 2021
Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 21, 2021
Gainers Gracell Biotechnologies (NASDAQ:GRCL) shares rose 21.25% to $17.69 during Friday's regular session. Trading volume for Gracell Biotechnologies's stock is...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 12, 2021
Gainers Intec Pharma (NASDAQ:NTEC) shares increased by 7.67% to $4.35 during Monday's after-market session. Intec Pharma's trading volume hit 412 shares by close,...
Via
Benzinga
55 Biggest Movers From Friday
May 03, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.